Mycenax Biotech Inc
TPEX:4726
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mycenax Biotech Inc
TPEX:4726
|
TW |
|
Fuchs Se
F:FPE3
|
DE |
|
S
|
SEACOR Marine Holdings Inc
F:SQZ
|
US |
|
G
|
GFT Technologies SE
XBER:GFT
|
DE |
|
S
|
Surteco Group SE
XBER:SUR
|
DE |
|
B
|
Basler AG
XHAM:BSL
|
DE |
|
B
|
Banco Santander SA
XHAN:BSD2
|
ES |
|
H
|
Halliburton Co
XHAN:HAL
|
US |
|
Fortrea Holdings Inc
F:K67
|
US |
Wall St Price Targets
Price Targets Summary
Mycenax Biotech Inc
According to Wall Street analysts, the average 1-year price target for Mycenax Biotech Inc is 42.84 TWD with a low forecast of 42.42 TWD and a high forecast of 44.1 TWD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Mycenax Biotech Inc's stock price target?
Price Target
42.84
TWD
According to Wall Street analysts, the average 1-year price target for Mycenax Biotech Inc is 42.84 TWD with a low forecast of 42.42 TWD and a high forecast of 44.1 TWD.
What is the Revenue forecast for Mycenax Biotech Inc?
Projected CAGR
41%
Over the last 13 years, the compound annual growth rate for Revenue has been 26%. The projected CAGR for the next 1 year is 41%.
